All In MedTech

Device type · CKG

Radioimmunoassay, Acth

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about CKG: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 20, 2026Source: openFDAMethods & limitations

Product code

CKG

Clinical Chemistry

Device class

Class II

FDA decisions since 2015

1

510(k), De Novo and PMA

Adverse event reports

2

Received Nov 1, 2025 to Nov 20, 2026

How FDA classifies it

Device type
Radioimmunoassay, Acth
Product code
CKG
Device class
Class II
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1025

Latest FDA decisions

All decisions for CKG

Reports received

2

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

2

100% of reports

Injury reports

0

0.0% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230000
Jan 240000
Feb 240000
Mar 240000
Apr 240000
May 240000
Jun 241000
Jul 240000
Aug 240000
Sep 240000
Oct 242000
Nov 240000
Dec 240000
Jan 250000
Feb 251000
Mar 250000
Apr 251000
May 250000
Jun 250000
Jul 250000
Aug 251000
Sep 250000
Oct 250000
Nov 250000
Dec 251000
Jan 261000
Feb 260000
Mar 260000
Apr 260000
May 260000
Jun 260000
Jul 260000
Aug 260000
Sep 260000
Oct 260000
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • High Test Results2

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions2

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Neurotransmitters BasicOpen, Classified

    GET TESTED INTERNATIONAL AB

    Z-0789-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025

    Reason given: Distribution without premarket approval/clearance.

    Cause as FDA categorized it: No Marketing Application

  • Neurotransmitters PlusOpen, Classified

    GET TESTED INTERNATIONAL AB

    Z-0790-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025

    Reason given: Distribution without premarket approval/clearance.

    Cause as FDA categorized it: No Marketing Application

  • Neurotransmitters XLOpen, Classified

    GET TESTED INTERNATIONAL AB

    Z-0791-2026 · Started Nov 3, 2025 · Posted by FDA Dec 1, 2025

    Reason given: Distribution without premarket approval/clearance.

    Cause as FDA categorized it: No Marketing Application

3 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.